Galectin Therapeutics, Inc. (GALT)
4.20
+0.06
(+1.45%)
USD |
NASDAQ |
Sep 09, 13:07
Galectin Therapeutics 1 Year Total Returns (Daily) : -11.35% for Sept. 8, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| September 08, 2026 | -11.35% |
| September 04, 2026 | -1.28% |
| September 03, 2026 | -3.12% |
| September 02, 2026 | 1.36% |
| September 01, 2026 | -2.57% |
| August 31, 2026 | -7.71% |
| August 28, 2026 | -5.41% |
| August 27, 2026 | 4.02% |
| August 26, 2026 | -0.24% |
| August 25, 2026 | -0.25% |
| August 24, 2026 | -5.37% |
| August 21, 2026 | -5.15% |
| August 20, 2026 | -8.46% |
| August 19, 2026 | -2.13% |
| August 18, 2026 | -9.74% |
| August 17, 2026 | -1.68% |
| August 14, 2026 | -8.51% |
| August 13, 2026 | -3.81% |
| August 12, 2026 | -16.71% |
| August 11, 2026 | -19.33% |
| August 10, 2026 | -24.82% |
| August 07, 2026 | -10.16% |
| August 06, 2026 | -14.59% |
| August 05, 2026 | -16.26% |
| August 04, 2026 | -16.85% |
| Date | Value |
|---|---|
| August 03, 2026 | -16.99% |
| July 31, 2026 | -18.41% |
| July 30, 2026 | -10.28% |
| July 29, 2026 | 5.76% |
| July 28, 2026 | 10.78% |
| July 27, 2026 | 16.15% |
| July 24, 2026 | 18.03% |
| July 23, 2026 | 22.34% |
| July 22, 2026 | 22.38% |
| July 21, 2026 | 40.33% |
| July 20, 2026 | 42.86% |
| July 17, 2026 | 44.46% |
| July 16, 2026 | 48.25% |
| July 15, 2026 | 70.00% |
| July 14, 2026 | 87.37% |
| July 13, 2026 | 83.27% |
| July 10, 2026 | 65.71% |
| July 09, 2026 | 94.22% |
| July 08, 2026 | 115.8% |
| July 07, 2026 | 114.4% |
| July 06, 2026 | 112.4% |
| July 02, 2026 | 107.8% |
| July 01, 2026 | 95.04% |
| June 30, 2026 | 119.9% |
| June 29, 2026 | 113.3% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 8.63% |
| Alnylam Pharmaceuticals, Inc. | -42.84% |
| Anika Therapeutics, Inc. | 135.3% |
| Savara, Inc. | 43.64% |
| Vericel Corp. | 17.64% |